Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA approves Afinitor in patients with advanced kidney cancer

March 31, 2009

PharmaMar and Taiho sign license agreement for antitumor drug Yondelis in Japan

March 31, 2009

Seattle Genetics receives FDA fast track for SGN-35 for Hodgkin's lymphoma

March 31, 2009

Infinity initiates phase II IPI-504 trial in HER2-positive breast cancer

March 31, 2009

Novel b-Raf inhibitors claimed by Takeda

March 31, 2009

Parvovirus H-1PV shows potential in pancreatic ductal adenocarcinoma therapy

March 30, 2009

Potent and efficacious PI3 kinase inhibitors identified for cancer treatment

March 30, 2009

FDA accepts for filing and review Spectrum's sNDA for Fusilev in colorectal cancer

March 30, 2009

Poniard completes patient enrollment in phase III SPEAR clinical trial of picoplatin in SCLC

March 30, 2009

Allos submits NDA to FDA for pralatrexate in relapsed or refractory PTCL

March 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...